These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2255675)
1. Cardiovascular effects of irindalone, a new S2-serotonergic antagonist, in the rat. Gradin K; Carlsson S; Hedner T; Persson B Pharmacol Toxicol; 1990 Sep; 67(3):199-204. PubMed ID: 2255675 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat. Gradin K; Hedner T; Persson B J Neural Transm Gen Sect; 1991; 83(3):227-33. PubMed ID: 1674420 [TBL] [Abstract][Full Text] [Related]
3. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat. Deckert V; Chaouloff F; Richer C; Elghozi JL Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665 [TBL] [Abstract][Full Text] [Related]
4. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat. Docherty JR; Warnock P J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073 [TBL] [Abstract][Full Text] [Related]
5. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats. Docherty JR J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414 [TBL] [Abstract][Full Text] [Related]
6. Hypotensive activity of serotonin antagonists; correlation with alpha 1-adrenoceptor and serotonin receptor blockade. Kalkman HO; Harms YM; van Gelderen EM; Batink HD; Timmermans PB; van Zwieten PA Life Sci; 1983 Mar; 32(13):1499-505. PubMed ID: 6300582 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of irindalone, a novel serotonin 5-HT2 antagonist and ketanserin on mechanical responses of rat thoracic aorta. Mikkelsen EO; Nyborg NC; Jensen KT; Boeck V Eur J Pharmacol; 1988 Apr; 149(1-2):145-8. PubMed ID: 3396624 [TBL] [Abstract][Full Text] [Related]
8. Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat. Schneider J; Fruh C; Wilffert B; Peters T Pharmacology; 1990; 40(1):33-41. PubMed ID: 1970437 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat. Pettersson A; Gradin K; Hedner T; Persson B Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):394-7. PubMed ID: 2993926 [TBL] [Abstract][Full Text] [Related]
10. Characterization of DOI, a putative 5-HT2 receptor agonist in the rat. Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Laubie M; Schmitt H Eur J Pharmacol; 1989 Sep; 168(3):369-74. PubMed ID: 2583242 [TBL] [Abstract][Full Text] [Related]
11. Vascular alpha 1D-adrenoceptors have a role in the pressor response to phenylephrine in the pithed rat. Zhou L; Vargas HM Eur J Pharmacol; 1996 Jun; 305(1-3):173-6. PubMed ID: 8813549 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity. Bøgesø KP; Arnt J; Boeck V; Christensen AV; Hyttel J; Jensen KG J Med Chem; 1988 Dec; 31(12):2247-56. PubMed ID: 2903929 [TBL] [Abstract][Full Text] [Related]
13. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Meller ST; Lewis SJ; Brody MJ; Gebhart GF Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336 [TBL] [Abstract][Full Text] [Related]
14. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat. Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B; Gradin K; Pettersson A; Hedner T J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509 [TBL] [Abstract][Full Text] [Related]
16. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms. Dedeoğlu A; Fisher LA J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059 [TBL] [Abstract][Full Text] [Related]
17. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat. McDaid J; Docherty JR Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260 [TBL] [Abstract][Full Text] [Related]
18. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat. Chaouche-Teyara K; Fournier B; Safar M; Dabiré H Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025 [TBL] [Abstract][Full Text] [Related]
19. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797 [TBL] [Abstract][Full Text] [Related]